AU2001263827B2 - 2-hydroxy-mutilin carbamate derivatives for antibacterial use - Google Patents

2-hydroxy-mutilin carbamate derivatives for antibacterial use Download PDF

Info

Publication number
AU2001263827B2
AU2001263827B2 AU2001263827A AU2001263827A AU2001263827B2 AU 2001263827 B2 AU2001263827 B2 AU 2001263827B2 AU 2001263827 A AU2001263827 A AU 2001263827A AU 2001263827 A AU2001263827 A AU 2001263827A AU 2001263827 B2 AU2001263827 B2 AU 2001263827B2
Authority
AU
Australia
Prior art keywords
ester
carbamic acid
compound
formula
hydroxymutilin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001263827A
Other languages
English (en)
Other versions
AU2001263827A1 (en
Inventor
Gerald Brooks
Steven Howard
Eric Hunt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0008260.2A external-priority patent/GB0008260D0/en
Priority claimed from GB0027182A external-priority patent/GB0027182D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001263827A1 publication Critical patent/AU2001263827A1/en
Application granted granted Critical
Publication of AU2001263827B2 publication Critical patent/AU2001263827B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU2001263827A 2000-04-04 2001-03-29 2-hydroxy-mutilin carbamate derivatives for antibacterial use Ceased AU2001263827B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0008260.2 2000-04-04
GBGB0008260.2A GB0008260D0 (en) 2000-04-04 2000-04-04 Novel compounds
GB0027182.5 2000-11-04
GB0027182A GB0027182D0 (en) 2000-11-04 2000-11-04 Novel comounds
PCT/EP2001/003594 WO2001074788A1 (en) 2000-04-04 2001-03-29 2-hydroxy-mutilin carbamate derivatives for antibacterial use

Publications (2)

Publication Number Publication Date
AU2001263827A1 AU2001263827A1 (en) 2002-01-03
AU2001263827B2 true AU2001263827B2 (en) 2004-06-17

Family

ID=26244040

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001263827A Ceased AU2001263827B2 (en) 2000-04-04 2001-03-29 2-hydroxy-mutilin carbamate derivatives for antibacterial use
AU6382701A Withdrawn AU6382701A (en) 2000-04-04 2001-03-29 2-hydroxy-mutilin carbamate derivatives for antibacterial use

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU6382701A Withdrawn AU6382701A (en) 2000-04-04 2001-03-29 2-hydroxy-mutilin carbamate derivatives for antibacterial use

Country Status (21)

Country Link
US (1) US6972297B2 (https=)
EP (1) EP1268443B1 (https=)
JP (1) JP2003529593A (https=)
KR (1) KR100758441B1 (https=)
CN (1) CN1210267C (https=)
AR (1) AR030203A1 (https=)
AT (1) ATE437860T1 (https=)
AU (2) AU2001263827B2 (https=)
BR (1) BR0109809A (https=)
CA (1) CA2405132A1 (https=)
CO (1) CO5280223A1 (https=)
CZ (1) CZ20023290A3 (https=)
DE (1) DE60139382D1 (https=)
ES (1) ES2328109T3 (https=)
HU (1) HUP0300370A3 (https=)
IL (1) IL151887A0 (https=)
MX (1) MXPA02009816A (https=)
NO (1) NO324229B1 (https=)
NZ (1) NZ521536A (https=)
PL (1) PL358666A1 (https=)
WO (1) WO2001074788A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024811D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
US7176310B1 (en) 2002-04-09 2007-02-13 Ucb Sa Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
DE60317208T2 (de) * 2002-07-24 2008-08-07 Nabriva Therapeutics Forschungs Gmbh Pleuromutilinderivate als antimikrobielle mittel
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
FR2856685B1 (fr) * 2003-06-25 2005-09-23 Merck Sante Sas Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP1863768A1 (en) * 2004-12-13 2007-12-12 Glaxo Group Limited Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl)carbamic acid 2-(s)-hydroxymutilin 14-ester
CA2591898A1 (en) * 2004-12-27 2006-07-06 Kyorin Pharmaceutical Co., Ltd. Mutilin-derivative substituted at position 12
JP2008534443A (ja) * 2005-03-10 2008-08-28 スミスクライン・ビーチャム・コーポレイション 新規な方法
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
KR100695541B1 (ko) * 2005-10-31 2007-03-16 한국단자공업 주식회사 연결터미널
WO2007079173A2 (en) * 2005-12-30 2007-07-12 Emergent Biosolutions Inc. Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
JP5322927B2 (ja) * 2007-05-24 2013-10-23 杏林製薬株式会社 １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2014640A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives
JP2010100582A (ja) * 2008-10-24 2010-05-06 Kyorin Pharmaceut Co Ltd １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
EP2253617A1 (de) 2009-05-20 2010-11-24 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
ES2843723T3 (es) * 2015-06-17 2021-07-20 Nabriva Therapeutics GmbH Formulaciones farmacéuticas inyectables de lefamulina
JP7631212B2 (ja) 2019-02-27 2025-02-18 オティカラ，インコーポレーテッド 鼻、副鼻腔、および鼻咽頭組織の感染および／または炎症を治療するための方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005659A1 (en) * 1996-08-02 1998-02-12 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4163254B2 (ja) 1996-01-03 2008-10-08 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ムチリンのカルバモイルオキシ誘導体および抗細菌剤としてのそれらの使用
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
FR2771008B1 (fr) 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005659A1 (en) * 1996-08-02 1998-02-12 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use

Also Published As

Publication number Publication date
HUP0300370A3 (en) 2005-07-28
PL358666A1 (en) 2004-08-09
HUP0300370A2 (hu) 2003-06-28
AR030203A1 (es) 2003-08-13
CN1427827A (zh) 2003-07-02
MXPA02009816A (es) 2003-03-27
JP2003529593A (ja) 2003-10-07
CA2405132A1 (en) 2001-10-11
EP1268443A1 (en) 2003-01-02
NO20024745L (no) 2002-11-19
US6972297B2 (en) 2005-12-06
CN1210267C (zh) 2005-07-13
CZ20023290A3 (cs) 2003-03-12
KR20030011815A (ko) 2003-02-11
BR0109809A (pt) 2003-01-21
AU6382701A (en) 2001-10-15
ES2328109T3 (es) 2009-11-10
NZ521536A (en) 2004-05-28
IL151887A0 (en) 2003-04-10
NO324229B1 (no) 2007-09-10
ATE437860T1 (de) 2009-08-15
NO20024745D0 (no) 2002-10-02
EP1268443B1 (en) 2009-07-29
DE60139382D1 (de) 2009-09-10
CO5280223A1 (es) 2003-05-30
WO2001074788A8 (en) 2001-12-20
US20030114674A1 (en) 2003-06-19
KR100758441B1 (ko) 2007-09-14
WO2001074788A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
AU2001263827B2 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
AU2001263827A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
SK91098A3 (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
IL135811A (en) Antimicrobial history of fluoromotilin converted at position 22, their preparation and pharmaceutical preparations containing them
AP872A (en) Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use.
WO2000027790A1 (en) Mutilin compounds
EP1351959B1 (en) Novel pleuromutilin derivatives
US20040058937A1 (en) Heterocyclic mutilin esters and their use as antibacterials
EP1355873B1 (en) Pleuromutilin derivatives with antimicrobial activity
WO2000007974A1 (en) 2-fluoro mutilin derivatives
ZA200207912B (en) 2-hydroxy-mitilin carbamate derivatives for antibacterial use.
WO2001014310A1 (en) PLEUROMUTILIN β-KETOESTERS
HK1078865A (en) Novel pleuromutilin derivatives

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired